mardi 9 juin 2015

Onco Actu du 9 juin 2015

1. Biologie

Yin and yang: Immune signaling protein has opposing roles in breast cancer development [MD Anderson Cancer Center]

Stanford researchers suss out cancer mutations in genome’s dark spots [Scope Blog]

Breast cancer spread 'trigger' discovered [The Guardian]

2.5 Etiologie - Gènes

Disease-Causing Mutations in Healthy People [The Scientist]

3.1 Tabac

Wales’s e-cigarette ban is irrational nanny statism at its worst [The Guardian]

E-cigarettes in enclosed public places could be banned in Wales [The Telegraph]

4. Dépistage, diagnostic et pronostic

Pre-natal blood test study leads to ‘unexpected’ cancer diagnosis in three women [Cancer Research UK]

Massachusetts Life Sciences Center and Dana-Farber Cancer Institute announce official opening of Dana-Farber's Molecular Cancer Imaging Facility [Dana-Farber Cancer Institute]

'Be on alert for bladder cancer' women advised [BBC News]

New Ways Doctors Reach Agreement on Patient Diagnoses [Wall Street Journal]

4.5 Dép., diag. & prono. - Colorectal

New Clues for Detecting Colorectal Cancers Earlier [Wall Street Journal]

4.9 Dép., diag. & prono. - Sein

Mandatory breast density reporting legislation: The law outpaces science, and not in a good way [Science-Based Medicine]

5.2 Pharma

Getting to the red zone in biopharma R&D (and thoughts on the 2015 Fierce 15) [FierceBiotech]

AbbVie to Present Data from Studies of the Company's Oncology Pipeline at the 20th European Hematology Association Annual Congress [AbbVie]

Novartis places big, broad bet on cancer immunotherapy [Reuters]

5.2.1 Pharma - Partenariats

Seattle Genetics Pays $25M to Buy Into Unum’s Souped-Up T-Cell Therapy [Xconomy]

Seattle Genetics and Unum Therapeutics Enter into Strategic Cancer Immunotherapy Collaboration [Seattle Genetics]

5.3 Traitements - FDA, EMA,...

EMA Reflects on Advanced Therapy Classification [RAPS]

Current status of European Medicines Agency policy on publication of clinical data - Stakeholder webinar [EMA]

5.4 Traitements - Economie

New Breakthrough Drugs Will Cost the U.S. Government How Much Money? [Wall Street Journal]

6. Lutte contre les cancers

Comprehensive Oncology Practice Business Guide Now Available [ASCO]

When Pain Persists After Breast Cancer Surgery [NY Times]

6.1 Observation

Women four times less likely to have surgery if breast cancer diagnosed as an emergency [Cancer Research UK]

Deaths from less common cancers on the rise [The Guardian]

6.11 Patients

Coping with cancer at university showed me who my friends are [The Guardian]

6.6 Publications

Fooling ourselves with science: hoaxes, retractions and the public [The Guardian]

Paying For Faster Peer Review [In the Pipeline]

Challenges, Connections, Conversations, and Collaboration – Lessons from the May 2015 ORCID-CASRAI Conference [The Scholarly Kitchen]

6.7 DMP, Big Data & applis

How Apple, Qualcomm & Lawyers will Revolutionize Healthcare [HIT Consultant]

6.8 Communication

Weak reporting of limitations of observational research [HealthNewsReview]